Zobrazeno 1 - 10
of 44
pro vyhledávání: '"T Higashio"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Tsutomu Masuda, Syusaku Yoshikawa, K Okamoto, T Higashio, Mizumi Inagaki, Naoki Inatsugi, Hideki Uchida, Takeshi Nakao, Y Shibata, Kentaro Yamaoka, Takashi Yokoo, S Terauchi
Publikováno v:
Journal of Crohn's and Colitis. 15:S223-S223
Background Previous studies have shown proximal extension (PE) rate of ulcerative proctitis (UP) is approximately 50%. This rate teach us the importance of treating UP adequately. Basically, we have to treat them with topical 5-ASA. But in clinical p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b699f02aaf98da54377d9798d8084c76
https://doi.org/10.1093/ecco-jcc/jjab076.262
https://doi.org/10.1093/ecco-jcc/jjab076.262
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Publikováno v:
Clinical Science. 55:11-14
1. Renin release from isolated dog renin granules was limited to within 20% of the total renin during incubation at 37°C in isotonic medium and did not depend on the external concentration of renin. 2. Although the renin granules were osmotically an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f372a3334899e2eb689f85d16f81718f
https://doi.org/10.1042/cs0550011
https://doi.org/10.1042/cs0550011
Autor:
T, Higashio, K, Kuroda
Publikováno v:
Arzneimittel-Forschung. 38(3)
Antagonistic effects of the new antihypertensive agent cadralazine (ethyl(+/-)-6-[ethyl(2-hydroxypropyl)-amino]-3-pyridazinecarbazate ) and its metabolite ISF-2405 [+/-)-6-[ethyl(2-hydroxypropyl)amino]-3-hydrazinopyridazine) on norepinephrine (NE), 5
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c8dde11526981ca04e6d646ff4e15e66
https://pubmed.ncbi.nlm.nih.gov/3382457
https://pubmed.ncbi.nlm.nih.gov/3382457
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 207(1)
Effects of bumetanide (2.5, 25 and 250 microgram/kg i.v.) on renal hemodynamics and function were investigated in anesthetized dogs using clearance methods, stop-flow analysis and radioactive microsphere. Under conditions of mild isotonic saline load
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ed821a72fc4553a2334e2c952798994e
https://pubmed.ncbi.nlm.nih.gov/702342
https://pubmed.ncbi.nlm.nih.gov/702342
Publikováno v:
Arzneimittel-Forschung. 38(3)
Hemodynamic effects of the newly synthesized vasodilator cadralazine (ethyl(+/)-6-[ethyl(2-hydroxypropyl)amino]-3- pyridazinecarbazate) were compared with those of hydralazine and budralazine in hexamethonium treated and non-treated anesthetized dogs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::efacf5fd4ce493e7b3233bba6c164095
https://pubmed.ncbi.nlm.nih.gov/3382459
https://pubmed.ncbi.nlm.nih.gov/3382459
Autor:
T, Higashio, K, Kuroda
Publikováno v:
Arzneimittel-Forschung. 38(3)
Antagonistic effects of the new antihypertensive agent cadralazine (ethyl(+/-)-6-[ethyl(2-hydroxypropyl)-amino]-3-pyridazinecarbazate ) and its metabolite ISF-2405 [+/-)-6-[ethyl(2-hydroxypropyl)amino]-3-hydrazinopyridazine) on contractile responses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::39ae21ef2c82e0818203665b063df615
https://pubmed.ncbi.nlm.nih.gov/3382458
https://pubmed.ncbi.nlm.nih.gov/3382458
Publikováno v:
Experientia. 36(2)
The renal effects of nine, 8-substituted derivatives of 3′,5′-cyclic monophosphate were studied in anesthetized mongrel dogs. Infusion of the compounds into a renal artery resulted in an increase of renal blood flow without any effect on blood pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4ad2cc795b21772ec4d0c1459ce27fd
https://pubmed.ncbi.nlm.nih.gov/6245910
https://pubmed.ncbi.nlm.nih.gov/6245910